Recursion Pharmaceuticals, Inc. (RXRX)
3.20
+0.04
(+1.27%)
USD |
NASDAQ |
Sep 11, 14:42
Recursion Pharmaceuticals Gross Profit (TTM) : -48.49M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -48.49M |
| March 31, 2026 | -46.21M |
| December 31, 2025 | -46.27M |
| September 30, 2025 | -70.08M |
| June 30, 2025 | -37.26M |
| March 31, 2025 | -22.70M |
| December 31, 2024 | -4.693M |
| September 30, 2024 | -2.141M |
| June 30, 2024 | -15.79M |
| March 31, 2024 | -17.07M |
| December 31, 2023 | -16.76M |
| September 30, 2023 | -1.49M |
| June 30, 2023 | -0.071M |
| Date | Value |
|---|---|
| March 31, 2023 | -6.735M |
| December 31, 2022 | -8.811M |
| September 30, 2022 | -11.54M |
| June 30, 2022 | -9.214M |
| March 31, 2022 | -2.585M |
| December 31, 2021 | -0.043M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Twist Bioscience Corp. | 224.38M |
| Absci Corp. | -9.533M |
| Novavax, Inc. | 325.46M |
| Editas Medicine, Inc. | 44.58M |
| Halozyme Therapeutics, Inc. | 1.271B |